25 results
Table of Antibiotics for Highly Resistant Gram Negative Infections 

Ceftazidime, Cefepime, Piperacillin/ Tazobactam, Carbapenems, Aztreonam, Aminoglycosides
Antibiotics for Highly Resistant ... #Antibiotics #Resistant ... #GramNegative # ... Infections #Table #Pharmacology ... Coverage #Management #resistance
IDSA - Doses of Drugs for Treatment of Adults and Children with Multidrug-Resistant Tuberculosis
Step 1 Levofloxacin,
IDSA - Doses of ... with Multidrug-Resistant ... Tuberculosis Step ... antimicrobials #pharmacology ... #dosing #idsa #
Parenteral Antimicrobial Treatment of Common Microorganisms Causing Native Vertebral Osteomyelitis - IDSA 
Staphylococci, oxacillin susceptible
Staphylococci, oxacillin
Osteomyelitis - IDSA ... Staphylococci, oxacillin resistant ... species, penicillin resistant ... management #treatment #pharmacology ... #idsa
IDSA - Prophylaxis to Prevent First Episode of Opportunistic Disease in HIV-AIDS
 • Pneumocystis pneumonia (PCP)
IDSA - Prophylaxis ... Mycobacterium tuberculosis ... #OIs #HIVAIDS #IDSA ... #management #pharmacology
Doses of Antituberculosis Drugs for Adults and Children - IDSA
First-line drugs:
 • Isoniazid
 • Rifampin
 •
and Children - IDSA ... Moxifloxacin #Tuberculosis ... Medications #management #pharmacology
IDSA - Prophylaxis to Prevent First Episode of Opportunistic Disease in HIV-AIDS
 • Pneumocystis pneumonia (PCP)
IDSA - Prophylaxis ... Mycobacterium tuberculosis ... #OIs #HIVAIDS #IDSA ... #management #pharmacology
IDSA Suggested Empiric Antibiotic Regimens Based on Clinical Severity for Diabetic Foot Infections
Mild (usually treated with
IDSA Suggested Empiric ... • Methicillin-resistant ... #antibiotics #pharmacology ... #idsa #podiatry
IDSA - Clinical Strategy to Build an Individualized Treatment Regimen for Multi-Drug Resistant Tuberculosis (MDR-TB)
 •
IDSA - Clinical ... for Multi-Drug Resistant ... Tuberculosis (MDR-TB ... isolate DST result should ... antimicrobials #regimens #pharmacology
Outpatient Treatment of with Community-Acquired Pneumonia (CAP)
No comorbidities or risk factors for MRSA or Pseudomonas aeruginosa:
local pneumococcal resistance ... fluoroquinolone #IDSA ... Management #Guidelines #pharmacology
IDSA Summary of recommendations on drugs for use in a treatment regimen for patients with
multidrug-resistant tuberculosis,
IDSA Summary of ... with multidrug-resistant ... tuberculosis, including ... antimicrobials #pharmacology ... #ebm #idsa